Source:http://linkedlifedata.com/resource/pubmed/id/18460550
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-6-25
|
pubmed:abstractText |
Adrenomedullin 2/intermedin (AM2/IMD) is a new member of calcitonin/calcitonin gene-related peptide family. AM is expressed in various tumors including adrenocortical tumors and modulates tumor growth. The AM2/IMD expression has not been studied, however, in adrenal tumors. The expression of AM2/IMD and AM was therefore studied in human adrenal tumors and attached non-neoplastic adrenal tissues by immunocytochemistry (ICC). Immunoreactive (IR)-AM2/IMD was measured by RIA. Furthermore, the expression of AM2/IMD and its receptor components, calcitonin receptor-like receptor (CRLR), and receptor activity-modifying proteins (RAMPs) 1, 2, and 3 mRNA in these tissues was studied by reverse transcription PCR (RT-PCR). ICC showed that AM2/IMD and AM immunoreactivities were localized in adrenocortical tumors and pheochromocytomas. AM2/IMD and AM immunoreactivities were detected in medulla of attached non-neoplastic tissues, while the degree of immunoreactivity for AM2/IMD and AM in cortices of attached adrenals was relatively weak or undetectable. RIA detected IR-AM2/IMD in adrenal tumors (0.414+/-0.12 to 0.786+/-0.27 pmol/g wet weight, mean+/-S.E.M.) and attached adrenal tissues (0.397+/-0.052 pmol/g wet weight). Reverse-phase high-performance liquid chromatography showed one broad peak eluted in the similar position to synthetic AM2/IMD with several minor peaks. RT-PCR showed expression of AM2/IMD, CRLR, and RAMP1, RAMP2, and RAMP3 mRNA in tissues of adrenal tumors and attached adrenal glands. In conclusion, AM2/IMD is expressed in human adrenal tumors and attached non-neoplastic adrenal tissues and may play (patho-)physiological roles in normal and neoplastic adrenals as an autocrine/paracrine regulator.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1479-6805
|
pubmed:author |
pubmed-author:AraiYoichiY,
pubmed-author:HiroseTakuoT,
pubmed-author:ImaiYutakaY,
pubmed-author:ItoSadayoshiS,
pubmed-author:MorimotoRyoR,
pubmed-author:MurakamiOsamuO,
pubmed-author:SasanoHironobuH,
pubmed-author:SatohFumitoshiF,
pubmed-author:SuzukiTakashiT,
pubmed-author:TakahashiKazuhiroK,
pubmed-author:TotsuneKazuhitoK
|
pubmed:issnType |
Electronic
|
pubmed:volume |
198
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-83
|
pubmed:dateRevised |
2010-9-24
|
pubmed:meshHeading |
pubmed-meshheading:18460550-Adrenal Gland Neoplasms,
pubmed-meshheading:18460550-Adrenal Glands,
pubmed-meshheading:18460550-Adrenocortical Carcinoma,
pubmed-meshheading:18460550-Adult,
pubmed-meshheading:18460550-Aged,
pubmed-meshheading:18460550-Female,
pubmed-meshheading:18460550-Humans,
pubmed-meshheading:18460550-Immunohistochemistry,
pubmed-meshheading:18460550-Male,
pubmed-meshheading:18460550-Middle Aged,
pubmed-meshheading:18460550-Peptide Hormones,
pubmed-meshheading:18460550-Pheochromocytoma,
pubmed-meshheading:18460550-RNA, Messenger,
pubmed-meshheading:18460550-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2008
|
pubmed:articleTitle |
Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues.
|
pubmed:affiliation |
Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8574, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|